Swedish Orphan Biovitrum AB (publ)

XBER:B6E

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is B6E's stock price target?

Price Target

31.87 EUR

According to Wall Street analysts, the average 1-year price target for B6E is 31.87 EUR with a low forecast of 20.85 EUR and a high forecast of 38.71 EUR.

What is the Revenue forecast for Swedish Orphan Biovitrum AB (publ)?

Projected CAGR

9%

Over the last 13 years, the compound annual growth rate for Revenue has been 23%. The projected CAGR for the next 8 years is 9%.

What is the Gross Profit forecast for Swedish Orphan Biovitrum AB (publ)?

Projected CAGR

9%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 27%. The projected CAGR for the next 8 years is 9%.

What is the Operating Income forecast for Swedish Orphan Biovitrum AB (publ)?

Projected CAGR

9%

The compound annual growth rate for Operating Income over the next 8 years is 9%.

What is the Pre-Tax Income forecast for Swedish Orphan Biovitrum AB (publ)?

Projected CAGR

600%

The compound annual growth rate for Pre-Tax Income over the next 3 years is 600%.

What is the Net Income forecast for Swedish Orphan Biovitrum AB (publ)?

Projected CAGR

43%

The compound annual growth rate for Net Income over the next 8 years is 43%.